Cambrex, the small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, has completed an expansion of its biopharmaceutical analysis capabilities at its Durham, NC site. Biopharmaceutical analysis services were initially launched at Durham in 2018 and have since been expanded through the purchase and implementation of various method development, validation, release and stability or endotoxin testing functions.   Following this expansio...